Year archive

FIREBRICK PHARMA LIMITED — 2023 filings

All 50 regulatory filings released by FIREBRICK PHARMA LIMITED (FRE) in 2023, sourced directly from the official regulator.

50 Filings

2023 Period

2023 filings (50)

Filing	Released	Lang
Firebrick Closes AAT Appeal 1 page 129.1KB Regulatory Filings	2023-12-26	English
Application for quotation of securities - FRE 6 pages 27.8KB Regulatory Filings	2023-12-18	English
Cleansing Notice 2 pages 140.7KB Regulatory Filings	2023-12-18	English
Nasodine COVID-19 Patent Granted in South Africa 2 pages 147.6KB Regulatory Filings	2023-11-28	English
Results of Annual General Meeting 2 pages 148.9KB Regulatory Filings	2023-11-16	English
Firebrick Investor Update 3 pages 177.0KB Regulatory Filings	2023-11-14	English
Firebrick Receives $1.81m R&D Tax Incentive 1 page Regulatory Filings	2023-10-30	English
September 2023 Quarterly Activity Report & Appendix 4C 9 pages 311.9KB Regulatory Filings	2023-10-26	English
Letter to Shareholders & Notice of AGM & Proxy Form 28 pages 607.7KB Regulatory Filings	2023-10-16	English
Update on Nasodine Trial and Forward Plans 2 pages 167.7KB Regulatory Filings	2023-10-02	English
Notice of AGM and Closing Date for Director Nominations 1 Regulatory Filings	2023-09-17	English
Phase 3 Common Cold Trial Results 3 pages 198.1KB Regulatory Filings	2023-09-12	English
Trading Halt 2 pages 636.0KB Regulatory Filings	2023-09-10	English
Appendix 4E & Annual Report FY23 52 pages 2.1MB Regulatory Filings	2023-08-28	English
Corporate Governance Statement 14 pages 417.4KB Regulatory Filings	2023-08-28	English
Appendix 4G 13 pages 359.0KB Regulatory Filings	2023-08-28	English
Response to ASX Price and Volume Query 5 pages 832.1KB Regulatory Filings	2023-08-27	English
Firebrick Phase 3 Trial Closes with 500 Subjects 2 pages 115.2KB Regulatory Filings	2023-08-08	English
Firebrick Covid-19 Trial Achieves Primary Endpoint 2 pages 149.8KB Regulatory Filings	2023-08-06	English
Update on Nasodine Phase 2 Study 1 page 126.5KB Regulatory Filings	2023-07-31	English
June 2023 Quarterly Activity Report & Appendix 4C 8 pages 322.2KB Regulatory Filings	2023-07-26	English
Firebrick Update on AAT Process 1 page 129.0KB Regulatory Filings	2023-07-19	English
Firebrick Update on Phase 2 Trial Results 1 page 12 Regulatory Filings	2023-07-11	English
Firebrick Update on AAT Schedule 1 page 127.4KB Regulatory Filings	2023-06-28	English
Application for quotation of securities - FRE 6 pages 27.7KB Regulatory Filings	2023-06-20	English
Change of Director's Interest Notice - Peter Molloy 3 pages 299.2KB Regulatory Filings	2023-06-20	English
Change of Director's Interest Notice - Stephen Goodall 3 pages 300.1KB Regulatory Filings	2023-06-20	English
Cleansing Notice 2 pages 168.5KB Regulatory Filings	2023-06-20	English
Firebrick Pharma Investor Update on Key Projects 2 pages 151.9KB Regulatory Filings	2023-06-19	English
Results of General Meeting 2 pages 148.1KB Regulatory Filings	2023-06-19	English
Notification of cessation of securities - FRE 4 pages 23.9KB Regulatory Filings	2023-06-15	English
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment 2 pages 159.9KB Regulatory Filings	2023-05-30	English
Update on Nasodine AAT Appeal Timetable 1 page 130. Regulatory Filings	2023-05-28	English
Letter to Shareholders & Notice of GM & Proxy Form 15 pages 952.0KB Regulatory Filings	2023-05-14	English
Nasodine Patent Allowed in Canada 2 pages 165.4KB Regulatory Filings	2023-05-08	English
Application for quotation of securities - FRE 6 pages 27.6KB Regulatory Filings	2023-05-08	English
Cleansing Notice 2 pages 110.8KB Regulatory Filings	2023-05-08	English
Firebrick Raises $1 million via Placement 2 pages 147.9KB Regulatory Filings	2023-04-30	English
Proposed issue of securities - FRE 5 pages 27.2KB Regulatory Filings	2023-04-30	English
Proposed issue of securities - FRE 5 pages 27.5KB Regulatory Filings	2023-04-30	English
March 2023 Quarterly Activity Report & Appendix 4C 8 pages 266.8KB Regulatory Filings	2023-04-19	English
Nasodine COVID-19 Trial Concludes Recruitment 3 pages 323.4KB Regulatory Filings	2023-04-02	English
Application for quotation of securities - FRE 6 pages 27.9KB Regulatory Filings	2023-03-27	English
Cleansing Notice 2 pages 134.7KB Regulatory Filings	2023-03-27	English
Firebrick Pharma's Phase 3 Trial of Nasodine Resumes 3 pages 371.9KB Regulatory Filings	2023-03-20	English
FRE files EU Paediatric Investigation Plan for Nasodine 2 pages 141.6KB Regulatory Filings	2023-02-20	English
Appendix 4D & Half Yearly Report and Accounts 26 pages 6.9MB Regulatory Filings	2023-02-16	English
Investor Presentation - Euroz Hartleys Healthcare Forum 20 pages 2.1MB Regulatory Filings	2023-01-31	English
December 2022 Quarterly Activity Report & Appendix 4C 9 pages 242.3KB Regulatory Filings	2023-01-18	English
Nasodine Research Points to Potential Role in CRS 2 pages 189.0KB Regulatory Filings	2023-01-17	English